Market Access/ News/ News Lilly cuts $1bn deal for Centrexion’s non-opioid painkiller Phil Taylor Centrexion, Lilly, non-opioid painkiller 0 Comment Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront Share X Lilly cuts $1bn deal for Centrexion’s non-opioid painkiller https://pharmaphorum.com/news/lilly-cuts-1bn-deal-for-centrexions-non-opioid-painkiller/
